The research peptide market in the United Kingdom is largely unregulated for grey-market supply. The MHRA has issued repeated warnings. A Certificate of Analysis from an independent laboratory is the only credible check you have.
This is The Dispatch — a broadsheet guide for anyone researching peptides in London and across the UK. We cover how to read a COA, what the MHRA framework actually says, how to spot a counterfeit, and why no purchase decision should precede a conversation with a licensed doctor.
Affiliate link — we may earn a small commission if you purchase. Disclosure & guide.
A peptide is a short chain of amino acids linked by peptide bonds — typically 2 to 50 amino acids in length. They are the building blocks of proteins and play roles in hormonal signalling, immune function, and cellular communication. Synthetic peptides are produced for research purposes and are categorised as Research Use Only (RUO) in the UK.
Research peptides exist in a legal grey area in the UK. Many are not licensed medicines and have no marketing authorisation from the MHRA. That status does not make them safe or of consistent quality — it means there is no mandatory quality control framework governing their production or supply.
The practical consequence is straightforward: a peptide sold through an unregulated channel carries no guarantee of identity, purity, or sterility. A vial labelled "99.5% pure BPC-157" may contain an entirely different compound, or the correct compound at a fraction of the stated purity. Without a COA from an independent laboratory, there is no basis for any other conclusion.
Verification is therefore not a bureaucratic formality. It is the only available check when regulatory controls do not apply. This guide explains exactly how that check works.
| Category | Example | UK Status | MHRA Controls? |
|---|---|---|---|
| Licensed medicine | Semaglutide (Ozempic) | Authorised — prescription only | Yes ✓ |
| Research peptide (RUO) | BPC-157, TB-500 | Unlicensed — grey market | No ✗ |
| GLP-1 analogue (unlicensed) | Tirzepatide (grey) | Unlicensed supply: MHRA offence | No ✗ |
| Dietary supplement | Collagen peptides | Food supplement rules apply | Partial ✗ |
A Certificate of Analysis is the single most important document when evaluating a peptide source. Here is what every field means and what to look for — or walk away from.
The COA must bear the same batch number as the vial you are evaluating. A COA without a batch number, or one whose number does not match the product label, provides no confirmation of what is actually inside that specific vial.
High-Performance Liquid Chromatography (HPLC) measures purity as a percentage. Liquid Chromatography–Mass Spectrometry (LC-MS) confirms molecular identity by mass. Both are required. Purity reported by HPLC alone, without LC-MS identity confirmation, is insufficient.
A credible purity result for research-grade peptides is 98% or higher. Values below this threshold should raise immediate concern. The methodology must be stated — a percentage figure without a stated method is not a measurement.
The testing laboratory must be independent of the supplier. Look for an ISO/IEC 17025 accreditation number, or equivalent UKAS accreditation in the UK. Laboratories that are part of the selling organisation cannot provide independent verification.
A credible COA bears the name (or initials) of the analyst and the date of testing. This creates a traceable record. An undated COA may not reflect the quality of the specific batch being supplied.
The COA must state the full compound name, its CAS registry number, and the confirmed molecular weight from LC-MS. Discrepancies between the stated and confirmed molecular weight are a sign of a different compound or significant impurity.
The research peptide grey market is rife with substandard and mislabelled products. These are the patterns that distinguish credible sources from those that should be avoided.
Before making any decision about a research peptide source, work through each of these steps. No source should proceed past a failed step.
Understanding the UK regulatory position is essential context for anyone researching peptides. This is not legal advice — it is an educational summary of publicly available MHRA guidance.
The Medicines Act 1968 and the Human Medicines Regulations 2012 are the primary legislative instruments governing medicines in the UK. Under these frameworks, any product that makes a medicinal claim — or that is administered to achieve a physiological effect — is considered a medicinal product and requires a marketing authorisation from the MHRA to be legally supplied.
Many research peptides are supplied and marketed explicitly as "not for human use" or "Research Use Only." The MHRA has noted that this labelling does not exempt a product from medicines law if it is, in practice, intended for human administration. The agency has taken enforcement action against suppliers marketing such products.
The MHRA also operates the Yellow Card Scheme, which collects adverse event reports. Unlicensed products, including research peptides, can and should be reported there if adverse reactions occur. This data informs future regulatory action.
For licensed GLP-1 receptor agonists (e.g., semaglutide branded as Ozempic or Wegovy), the MHRA has issued specific guidance warning against purchasing unlicensed or counterfeit versions, which have proliferated as demand for these medicines has grown.
Sources: MHRA Human Medicines Regulations 2012 · MHRA Yellow Card Scheme · Medicines Act 1968 · MHRA enforcement update 2025. Last reviewed: July 2026.Understand what a peptide is, how it works at a molecular level, and why it sits in a grey regulatory area in the UK.
Speak to a licensed GP or specialist before any other step. No verification process substitutes for medical supervision and personal health context.
Obtain the batch-specific COA. Verify laboratory independence, HPLC purity ≥ 98%, and LC-MS identity confirmation.
Review the MHRA position on the specific compound you are researching. Know what is and is not permitted under the Human Medicines Regulations 2012.
With verified COA, medical guidance, and regulatory understanding in place, you are equipped to make a genuinely informed decision.
A comprehensive guide covering: what a peptide is, how to read a COA, verification protocols, independent laboratory testing, MHRA framework, and medical supervision. Direct download — no registration required.
Download the Guide (PDF)A chain of 2–50 amino acids linked by peptide bonds. Synthetic peptides are produced for research purposes and are not licensed medicines in the UK.
Certificate of Analysis. A laboratory document reporting identity, purity, and batch information for a compound. Must come from an independent, accredited laboratory.
High-Performance Liquid Chromatography. An analytical technique that separates and quantifies the components of a sample, reporting purity as a percentage.
Liquid Chromatography–Mass Spectrometry. Confirms the molecular identity of a compound by measuring its mass. Gold standard for peptide identity verification.
Medicines and Healthcare products Regulatory Agency. The UK body that authorises and regulates medicines and medical devices. Website: gov.uk/mhra.
Research Use Only. A designation indicating a compound is not approved for human use. Does not exempt the product from MHRA oversight if it is intended for human administration.
A unique identifier for a specific production run. A valid COA must reference the same batch number as the product label — it is the only link between the test result and the physical vial.
The international standard for the competence of testing and calibration laboratories. UK laboratories may also hold UKAS accreditation under this standard.
No verification protocol, however thorough, replaces a consultation with a licensed doctor or healthcare professional. A GP or specialist with knowledge of your individual health history can advise whether any research compound is appropriate, identify contraindications, and ensure that any use is medically supervised.
In the UK, your GP is your first point of contact. Private clinics specialising in longevity, endocrinology, or sports medicine may also be appropriate depending on the compound. Do not make any decision about a research peptide without this step in place.
A field-by-field guide to understanding a Certificate of Analysis — what each element means and what to look for.
CounterfeitsHow to identify the warning signs of a substandard or mislabelled peptide product before any commitment is made.
Lab TestingWhy independent laboratory testing is the only meaningful basis for purity claims and how to assess it.
MHRA · UK LawAn accessible guide to the UK regulatory position on research peptides under the Human Medicines Regulations 2012.
Purity StandardsWhat the 98% purity standard means, why it matters, and how HPLC and LC-MS testing methods achieve it.